Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Feasibility and Phase II Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors.

NCT00851110 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT00851110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00851110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Feasibility and Phase II Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors.
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2004
Completion date
Not reported
Enrollment
50 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk breast cancer